(IBKR) Interactive Brokers - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US45841N1072
Stock: Trading, Custody, Lending, Brokerage
Total Rating 66
Risk 58
Buy Signal -0.11
| Risk 5d forecast | |
|---|---|
| Volatility | 42.7% |
| Relative Tail Risk | -5.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.90 |
| Alpha | 11.90 |
| Character TTM | |
|---|---|
| Beta | 1.601 |
| Beta Downside | 2.322 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.74% |
| CAGR/Max DD | 1.29 |
EPS (Earnings per Share)
Revenue
Description: IBKR Interactive Brokers March 05, 2026
Interactive Brokers Group, Inc. (IBKR) operates as an automated electronic broker globally. The company facilitates trading in a broad range of financial instruments, including stocks, options, futures, and cryptocurrencies. This diverse offering is characteristic of the online brokerage sector, which has expanded beyond traditional asset classes.
IBKR also provides custody and service accounts for various client types, such as hedge funds, registered investment advisors, and individual investors. Its business model includes prime brokerage, securities, and margin lending services, catering to institutional and individual clients through electronic exchanges. The investment banking and brokerage industry is highly competitive, with firms often differentiating themselves through technology and breadth of services.
For more in-depth analysis, consider exploring ValueRays comprehensive reports.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 984.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.97 > 1.0 |
| NWC/Revenue: -604.4% < 20% (prev 220.0%; Δ -824.3% < -1%) |
| CFO/TA 0.08 > 3% & CFO 15.81b > Net Income 984.0m |
| Net Debt (-4.94b) to EBITDA (9.09b): -0.54 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (447.9m) vs 12m ago 2.08% < -2% |
| Gross Margin: 89.78% > 18% (prev 0.88%; Δ 8890 % > 0.5%) |
| Asset Turnover: 5.79% > 50% (prev 5.52%; Δ 0.27% > 0%) |
| Interest Coverage Ratio: 2.13 > 6 (EBITDA TTM 9.09b / Interest Expense TTM 4.22b) |
Altman Z'' -1.57
| A: -0.30 (Total Current Assets 95.44b - Total Current Liabilities 157.28b) / Total Assets 203.24b |
| B: 0.02 (Retained Earnings 3.12b / Total Assets 203.24b) |
| C: 0.05 (EBIT TTM 8.99b / Avg Total Assets 176.69b) |
| D: 0.03 (Book Value of Equity 5.36b / Total Liabilities 182.77b) |
| Altman-Z'' Score: -1.57 = D |
Beneish M
| DSRI: 1.09 (Receivables 90.47b/67.07b, Revenue 10.23b/8.29b) |
| GMI: 0.98 (GM 89.78% / 87.68%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.23 (Revenue 10.23b / 8.29b) |
| TATA: -0.07 (NI 984.0m - CFO 15.81b) / TA 203.24b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of IBKR shares?
As of March 07, 2026, the stock is trading at USD 66.70 with a total of 4,239,329 shares traded.
Over the past week, the price has changed by -6.31%, over one month by -10.48%, over three months by +1.46% and over the past year by +41.15%.
Over the past week, the price has changed by -6.31%, over one month by -10.48%, over three months by +1.46% and over the past year by +41.15%.
Is IBKR a buy, sell or hold?
Interactive Brokers has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy IBKR.
- StrongBuy: 4
- Buy: 3
- Hold: 1
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the IBKR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 80.6 | 20.8% |
| Analysts Target Price | 80.6 | 20.8% |
IBKR Fundamental Data Overview March 06, 2026
P/E Trailing = 31.1487
P/E Forward = 30.6748
P/S = 18.9323
P/B = 5.7632
P/EG = 2.4606
Revenue TTM = 10.23b USD
EBIT TTM = 8.99b USD
EBITDA TTM = 9.09b USD
Long Term Debt = 894.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 19.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.94b USD (from netDebt column, last quarter)
Enterprise Value = 112.61b USD (117.55b + Debt 19.0m - CCE 4.96b)
Interest Coverage Ratio = 2.13 (Ebit TTM 8.99b / Interest Expense TTM 4.22b)
EV/FCF = 7.15x (Enterprise Value 112.61b / FCF TTM 15.74b)
FCF Yield = 13.98% (FCF TTM 15.74b / Enterprise Value 112.61b)
FCF Margin = 153.9% (FCF TTM 15.74b / Revenue TTM 10.23b)
Net Margin = 9.62% (Net Income TTM 984.0m / Revenue TTM 10.23b)
Gross Margin = 89.78% ((Revenue TTM 10.23b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 91.12% (prev 90.83%)
Tobins Q-Ratio = 0.55 (Enterprise Value 112.61b / Total Assets 203.24b)
Interest Expense / Debt = 5821 % (Interest Expense 1.11b / Debt 19.0m)
Taxrate = 7.62% (99.0m / 1.30b)
NOPAT = 8.31b (EBIT 8.99b * (1 - 7.62%))
Current Ratio = 0.61 (Total Current Assets 95.44b / Total Current Liabilities 157.28b)
Debt / Equity = 0.00 (Debt 19.0m / totalStockholderEquity, last quarter 5.36b)
Debt / EBITDA = -0.54 (Net Debt -4.94b / EBITDA 9.09b)
Debt / FCF = -0.31 (Net Debt -4.94b / FCF TTM 15.74b)
Total Stockholder Equity = 4.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.56% (Net Income 984.0m / Total Assets 203.24b)
RoE = 19.88% (Net Income TTM 984.0m / Total Stockholder Equity 4.95b)
RoCE = 153.9% (EBIT 8.99b / Capital Employed (Equity 4.95b + L.T.Debt 894.0m))
RoIC = 162.2% (NOPAT 8.31b / Invested Capital 5.12b)
WACC = 11.81% (E(117.55b)/V(117.57b) * Re(11.81%) + (debt cost/tax rate unavailable))
Discount Rate = 11.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.91%
[DCF] Terminal Value 69.90% ; FCFF base≈12.92b ; Y1≈15.93b ; Y5≈27.14b
[DCF] Fair Price = 587.4 (EV 256.64b - Net Debt -4.94b = Equity 261.59b / Shares 445.4m; r=11.81% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 96.39 | EPS CAGR: 35.16% | SUE: 2.46 | # QB: 3
Revenue Correlation: 83.35 | Revenue CAGR: 42.21% | SUE: 2.94 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.59 | Chg7d=-0.003 | Chg30d=+0.002 | Revisions Net=+6 | Analysts=7
EPS current Year (2026-12-31): EPS=2.44 | Chg7d=-0.008 | Chg30d=+0.007 | Revisions Net=+5 | Growth EPS=+11.6% | Growth Revenue=+11.3%
EPS next Year (2027-12-31): EPS=2.74 | Chg7d=-0.014 | Chg30d=+0.003 | Revisions Net=+5 | Growth EPS=+12.1% | Growth Revenue=+8.0%
[Analyst] Revisions Ratio: +1.00 (6 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.6% (Discount Rate 11.8% - Earnings Yield 3.2%)
[Growth] Growth Spread = +4.9% (Analyst 13.5% - Implied 8.6%)
P/E Forward = 30.6748
P/S = 18.9323
P/B = 5.7632
P/EG = 2.4606
Revenue TTM = 10.23b USD
EBIT TTM = 8.99b USD
EBITDA TTM = 9.09b USD
Long Term Debt = 894.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 19.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.94b USD (from netDebt column, last quarter)
Enterprise Value = 112.61b USD (117.55b + Debt 19.0m - CCE 4.96b)
Interest Coverage Ratio = 2.13 (Ebit TTM 8.99b / Interest Expense TTM 4.22b)
EV/FCF = 7.15x (Enterprise Value 112.61b / FCF TTM 15.74b)
FCF Yield = 13.98% (FCF TTM 15.74b / Enterprise Value 112.61b)
FCF Margin = 153.9% (FCF TTM 15.74b / Revenue TTM 10.23b)
Net Margin = 9.62% (Net Income TTM 984.0m / Revenue TTM 10.23b)
Gross Margin = 89.78% ((Revenue TTM 10.23b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 91.12% (prev 90.83%)
Tobins Q-Ratio = 0.55 (Enterprise Value 112.61b / Total Assets 203.24b)
Interest Expense / Debt = 5821 % (Interest Expense 1.11b / Debt 19.0m)
Taxrate = 7.62% (99.0m / 1.30b)
NOPAT = 8.31b (EBIT 8.99b * (1 - 7.62%))
Current Ratio = 0.61 (Total Current Assets 95.44b / Total Current Liabilities 157.28b)
Debt / Equity = 0.00 (Debt 19.0m / totalStockholderEquity, last quarter 5.36b)
Debt / EBITDA = -0.54 (Net Debt -4.94b / EBITDA 9.09b)
Debt / FCF = -0.31 (Net Debt -4.94b / FCF TTM 15.74b)
Total Stockholder Equity = 4.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.56% (Net Income 984.0m / Total Assets 203.24b)
RoE = 19.88% (Net Income TTM 984.0m / Total Stockholder Equity 4.95b)
RoCE = 153.9% (EBIT 8.99b / Capital Employed (Equity 4.95b + L.T.Debt 894.0m))
RoIC = 162.2% (NOPAT 8.31b / Invested Capital 5.12b)
WACC = 11.81% (E(117.55b)/V(117.57b) * Re(11.81%) + (debt cost/tax rate unavailable))
Discount Rate = 11.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.91%
[DCF] Terminal Value 69.90% ; FCFF base≈12.92b ; Y1≈15.93b ; Y5≈27.14b
[DCF] Fair Price = 587.4 (EV 256.64b - Net Debt -4.94b = Equity 261.59b / Shares 445.4m; r=11.81% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 96.39 | EPS CAGR: 35.16% | SUE: 2.46 | # QB: 3
Revenue Correlation: 83.35 | Revenue CAGR: 42.21% | SUE: 2.94 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.59 | Chg7d=-0.003 | Chg30d=+0.002 | Revisions Net=+6 | Analysts=7
EPS current Year (2026-12-31): EPS=2.44 | Chg7d=-0.008 | Chg30d=+0.007 | Revisions Net=+5 | Growth EPS=+11.6% | Growth Revenue=+11.3%
EPS next Year (2027-12-31): EPS=2.74 | Chg7d=-0.014 | Chg30d=+0.003 | Revisions Net=+5 | Growth EPS=+12.1% | Growth Revenue=+8.0%
[Analyst] Revisions Ratio: +1.00 (6 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.6% (Discount Rate 11.8% - Earnings Yield 3.2%)
[Growth] Growth Spread = +4.9% (Analyst 13.5% - Implied 8.6%)